AlphaCrest Capital Management’s Ingevity NGVT Stock Holding History

AlphaCrest Capital Management’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-17,006	Closed	-$1.03M	–	754
2022 Q3	$1.03M	Buy	17,006 +619	+4%	+$41.5K	0.06%	588
2022 Q2	$1.03M	Buy	+16,387	New	+$1.07M	0.05%	646
2022 Q1	–	Sell	-14,052	Closed	-$1.01M	–	1353
2021 Q4	$1.01M	Sell	14,052 -1,360	-9%	-$103K	0.04%	786
2021 Q3	$1.1M	Buy	+15,412	New	+$1.22M	0.06%	580
2021 Q1	–	Sell	-2,900	Closed	-$220K	–	1263
2020 Q4	$220K	Sell	2,900 -4,100	-59%	-$267K	0.02%	1042
2020 Q3	$346K	Sell	7,000 -300	-4%	-$16.9K	0.04%	794
2020 Q2	$384K	Buy	+7,300	New	+$346K	0.06%	505
2020 Q1	–	Sell	-6,800	Closed	-$594K	–	1192
2019 Q4	$594K	Buy	6,800 +2,100	+45%	+$184K	0.05%	673
2019 Q3	$399K	Buy	+4,700	New	+$419K	0.02%	1017

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ICP

Inclusive Capital Partners San Francisco, California $26M AUM 22.24% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BBCM

Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return

MRCP

Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return

AlphaCrest Capital Management's NGVT Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Ingevity (NGVT) in Q4 2022, closing a stake of 17,006 shares — an estimated $1.03M sold.

AlphaCrest Capital Management first reported a position in NGVT in Q3 2019 and held it in 9 quarters. The position peaked at $1.1M in Q3 2021. 293 funds tracked by Wall St. Rank hold NGVT as of Q4 2022.

AlphaCrest Capital Management reported no remaining Ingevity position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 17,006 Ingevity shares in Q4 2022, an estimated $1.03M.
AlphaCrest Capital Management first reported a position in Ingevity in Q3 2019 and held it in 9 quarters.
AlphaCrest Capital Management's Ingevity position peaked at $1.1M in Q3 2021.
293 funds tracked by Wall St. Rank held Ingevity as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.